Clinical trials recruiting in Oman

Phase breakdown

Cities in Oman

Conditions recruiting in Oman

Recruiting trials in Oman

• A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
  NCT05953584 · Phase: Phase 2 · Ages: 12 Years to 16 Years · Sex: All (male and female)
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female)
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
  NCT05894239 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial
  NCT07413055 · Phase: Phase 3 · Ages: 21 Years to 80 Years · Sex: All (male and female)
• INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
  NCT06314282 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
  NCT07491042 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years and older · Sex: All (male and female)
• Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
  NCT04657822 · Phase: Phase 4 · Ages: 6 Months to 100 Years · Sex: All (male and female)
• The Effect of Using Weighted Blanket on Anxiety, Stress, Depression and Comfort Level Among Patients With Cancer Undergoing Intravenous Anticancer Therapy and Its Feasibility of Use by Nurses Compared to Routine Care
  NCT07653035 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
  NCT06975865 · Phase: Phase 3 · Ages: 10 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Oman?

10 recruiting trials have at least one study site in Oman.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.